Evaluation of 123-I Iodobenzovesamicol (IBVM) and SPECT Imaging of Healthy Subjects and Patients With Alzheimer Disease (IBVM001)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00480701
Recruitment Status : Completed
First Posted : May 31, 2007
Last Update Posted : May 7, 2014
Information provided by (Responsible Party):
Danna Jennings, MD, Institute for Neurodegenerative Disorders

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : October 2011
  Study Completion Date : October 2011
  Certification/Extension First Submitted : March 21, 2014